Skip to content
VisionGate LogoVisionGate LogoVisionGate Logo
  • Home
  • About
    • Our Team
  • Our Technology
    • Non-Intrusive Testing
    • Patented Cell-CT Imaging
    • AI Powered Detection
  • Blog
    • News
    • Patents
    • Publications
    • Research
  • Contact

Blog

  • NewsFPO
  • Patents
  • Publications
  • ResearchFPO
  • December 5, 2016

    VisionGate Presents at the World Conference on Lung Cancer for 2016 in Vienna: The Non-Invasive LuCED® test for Detection of Early Stage Lung Cancer

    More Information

    Research

  • December 5, 2016

    VisionGate Presents at the World Conference on Lung Cancer for 2016 in Vienna: Non-Invasive LuCED® Test for Endobronchial Dysplasia, Enabling Chemoprevention Therapy with Drugs Such as Iloprost

    More Information

    Research

  • November 17, 2016

    VisionGate to Speak for the Exclusive Piper Jaffray Conference

    More Information

    News

  • April 28, 2016

    VisionGate’s Alan Nelson Named Academy of Inventors Fellow

    More Information

    News

  • March 16, 2016

    VisionGate Receives Strategic Investment from Trinnovate Ventures

    More Information

    News

  • February 5, 2016

    VisionGate to Present at Leerink Partners Global Healthcare Conference

    More Information

    News

  • September 16, 2015

    VisionGate Presents at the 2015 Conference of the American Society of Pathologists: Three Dimensional Cytologic Examination: Performance of the Cytopathologist Review Using CellGazer in the LuCED® Test for Lung Cancer Screening

    More Information

    Research

  • September 11, 2015

    VisionGate Presents at the World Conference on Lung Cancer for 2015 in Denver:Blinded Clinical Study of the LuCED® Test for Detection of Early Stage Lung Cancer

    More Information

    Research

  • July 9, 2015

    A Description of LuCED Technology and LuCED Performance Published in the Same Edition of the American Cancer Society Journal, Cancer Cytopathology

    More Information

    Publications

  • April 1, 2015

    World renowned surgeon joins VisionGate’s Medical Advisory Board

    More Information

    News

Previous345Next
visiongate logo retina logo

Follow Us

x icon
  • Home
  • About
  • Our Technology
Contact

© Copyright 2005 – 2025 | VisionGate, Inc | Milwaukee Web Design by Flipeleven | All Rights Reserved

3 Questions to Assess Your Risk

 Early detection of lung cancer is important to keeping you healthy and living your life to the fullest.

Has a family member had Lung Cancer? *
Have you smoked or been exposed to secondhand smoke? *

If you are over the age of 60 or answer "Yes" to any of the questions above, you may be at an increased risk.

This test is not a diagnosis but can help you recognize factors that may increase your risk of developing lung cancer. Next, You can subscribe to learn more from VisionGate. Then, you'll be redirected to a page of resources that can aid you in discussions with your doctor, or click here to access the page directly.

If you are above the age of 50 and answered "Yes" to any of the questions, you may be at an increased risk of developing lung cancer, but this is not a diagnosis. Use the link below to download resources that can help you talk to your doctor. Click Here to Download
We're sorry! There was an error submitting the test. Please try again later.

*No personal information is collected or saved through this form without your consent. Only your email and name will be saved if you opt-in.

visiongate logo
Contact
  • Home
  • About
  • Our Technology

© Copyright 2005 – 2025 | VisionGate, Inc | Milwaukee Web Design by Flipeleven | All Rights Reserved

Page load link
Go to Top